StockData
Myriad Genetics Inc logo

Myriad Genetics Inc (MYGN) stock

MYGNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3070% below fair value
$5.54−0.03 (-0.54%)

Close on Nov 17, 2026Market cap $529.90MP/E –Yield –

Myriad Genetics operating margin

Operating margin is operating income as a percentage of revenue.

Myriad Genetics's operating margin for the twelve months ending Jun 30, 2026 was -12.2%. For fiscal 2025 it was -47.0%, against -14.7% the year before. The highest annual figure on record is 39.2% in fiscal 2011.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-47.0%−32.2
FY2024Dec 31, 2024-14.7%+19.4
FY2023Dec 31, 2023-34.2%−13.4
FY2022Dec 31, 2022-20.7%+15.6
FY2020Jun 30, 2020-36.3%−37.2
FY2019Jun 30, 20190.9%−15.5
FY2018Jun 30, 201816.4%+10.4
FY2017Jun 30, 20176.0%−14.7
FY2016Jun 30, 201620.7%+2.2
FY2015Jun 30, 201518.5%−16.8
FY2014Jun 30, 201435.3%−1.9
FY2013Jun 30, 201337.2%+0.8
FY2012Jun 30, 201236.4%−2.9
FY2011Jun 30, 201139.2%+2.0
FY2010Jun 30, 201037.2%−1.5
FY2009Jun 30, 200938.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q2 FY2026CQ2 2026Jun 30, 2026-20.4%+134.1
Q1 FY2026CQ1 2026Mar 31, 2026-15.3%−0.5
Q4 FY2025CQ4 2025Dec 31, 2025-2.7%+15.8
Q3 FY2025CQ3 2025Sep 30, 2025-11.3%−2.0
Q2 FY2025CQ2 2025Jun 30, 2025-154.5%−137.2
Q1 FY2025CQ1 2025Mar 31, 2025-14.8%−1.0
Q4 FY2024CQ4 2024Dec 31, 2024-18.5%−2.5
Q3 FY2024CQ3 2024Sep 30, 2024-9.4%+21.9
Q2 FY2024CQ2 2024Jun 30, 2024-17.3%+44.7
Q1 FY2024CQ1 2024Mar 31, 2024-13.8%+15.0
Q4 FY2023CQ4 2023Dec 31, 2023-16.0%+13.4
Q3 FY2023CQ3 2023Sep 30, 2023-31.3%−2.5
Q2 FY2023CQ2 2023Jun 30, 2023-62.0%−52.0
Q1 FY2023CQ1 2023Mar 31, 2023-28.8%−13.3
Q4 FY2022CQ4 2022Dec 31, 2022-29.4%+43.9
Q3 FY2022CQ3 2022Sep 30, 2022-28.8%+52.8
Q2 FY2022CQ2 2022Jun 30, 2022-9.9%−5.4
Q1 FY2022CQ1 2022Mar 31, 2022-15.5%−4.3
Q4 FY2020CQ2 2020Jun 30, 2020-73.3%−70.7
Q3 FY2020CQ1 2020Mar 31, 2020-81.5%−84.2
Q2 FY2020CQ4 2019Dec 31, 2019-4.5%−7.3
Q1 FY2020CQ3 2019Sep 30, 2019-11.2%−11.8
Q4 FY2019CQ2 2019Jun 30, 2019-2.6%−11.8
Q3 FY2019CQ1 2019Mar 31, 20192.7%−4.8
Q2 FY2019CQ4 2018Dec 31, 20182.8%−0.5
Q1 FY2019CQ3 2018Sep 30, 20180.6%−46.4
Q4 FY2018CQ2 2018Jun 30, 20189.2%−0.3
Q3 FY2018CQ1 2018Mar 31, 20187.5%+4.7
Q2 FY2018CQ4 2017Dec 31, 20173.4%−5.4
Q1 FY2018CQ3 2017Sep 30, 201747.0%+43.0
Q4 FY2017CQ2 2017Jun 30, 20179.5%−3.4
Q3 FY2017CQ1 2017Mar 31, 20172.8%−19.5
Q2 FY2017CQ4 2016Dec 31, 20168.7%−14.6
Q1 FY2017CQ3 2016Sep 30, 20164.0%−19.6
Q4 FY2016CQ2 2016Jun 30, 201612.8%−6.0
Q3 FY2016CQ1 2016Mar 31, 201622.4%+2.5
Q2 FY2016CQ4 2015Dec 31, 201523.4%–
Q1 FY2016CQ3 2015Sep 30, 201523.6%–
Q4 FY2015CQ2 2015Jun 30, 201518.8%–
Q3 FY2015CQ1 2015Mar 31, 201519.8%–

More Myriad Genetics figures

See a number that looks wrong?